updates from the cheiron study: docetaxel plus enzalutamide for mcrpc
Published 5 years ago • 91 plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
4:17
cheiron study: docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patie...
-
1:57
enzalutamide after docetaxel for mcrpc: evaluation by the italian named patient program
-
1:25
procaid: capivasertib plus docetaxel and prednisolone chemotherapy for the treatment of mcrpc
-
4:50
interview with dr. caffo
-
1:10
preside: investigating continued treatment with enzalutamide in pc following disease progression
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
2:34
first-line treatments for patients with mhspc and mcrpc
-
6:49
ramp: phase ib study of rucaparib & enzalutamide in mcrpc
-
1:37
dr. caffo discusses enzalutamide/docetaxel combination in frontline mcrpc
-
1:44
talapro-2: exposure-safety of talazoparib enzalutamide in mcrpc
-
4:25
cabozantinib plus docetaxel and prednisone in mcrpc
-
2:45
arrow: psma-targeted radioligand therapy plus enzalutamide in mcrpc
-
18:57
disease management for mcrpc
-
1:24
dr. posadas on a phase ib study of abiraterone plus docetaxel for mcrpc
-
3:57
update on arches trial: implications for prostate cancer treatment
-
0:42
enzalutamide in the non-metastatic setting for crpc
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
1:55
awaiting key results for enzalutamide and apalutamide in nmcrpc
-
5:59
apalutamide in combination with abiraterone acetate, docetaxel and prednisone for mcrpc